Chemcrux Enterprises

₹79.16As of Sun 8 Nov 2026, 12:00 UTC

NSE:CHEMCRUX—

Country India

PE (Fwd) 29.95

TSR 10Y CAGR —

Div yield 1.26%

ROE —

Chemicals and Allied Products

Beta (5Y) —

PE TTM 31.42

TSR TTM —

Mkt cap ₹1.177B

ROIC —

SE Grade™

—

Value

—

Quality

Moat

—

1Y Price

Reference

₹85

—

7.97%

—

FY23

FY24

FY25

FY26

Earnings per share₹

9.70

5.70

2.64

2.52

(3.33%)

(41.21%)

(53.68%)

(4.57%)

Revenue₹M

951.5

784.7

700.1

806.5

(0.12%)

(17.54%)

(10.78%)

15.19%

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

806.5

Revenue₹M

—

952.7

951.5

784.7

700.1

806.5

825.9

(4.08%)

15.19

Revenue growth%

—

(0.12)

(17.54)

(10.78)

15.19

2.40

(5.45)

—

58.04

Gross margin%

—

47.30

54.01

58.64

59.13

58.04

58.24

58.04

8.27

Operating margin%

—

20.48

20.53

14.47

8.94

8.27

14.47

4.63

Net margin%

—

15.60

15.09

10.76

5.59

4.63

4.61

10.76

31.42

P/E ratio (avg)x

—

30.79

—

17.57

EV/EBITx

—

17.16

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

2.52

EPS₹

—

10.03

9.70

5.70

2.64

2.52

2.57

(29.21%)

—

(4.66)

EPS growth%

—

(3.37)

(41.19)

(53.66)

(4.66)

2.05

(22.92)

—

Bookvalue per sh₹

—

FCF per share₹

—

1.00

Dividend per sh₹

—

2.00

1.00

0.99

(15.91%)

—

1.26

Div yield (avg)%

—

1.25

—

39.69

Payout ratio%

—

19.94

20.63

17.54

37.88

39.69

38.43

20.63

—

14.81

Shares (diluted)M

—

14.81

◌14.81

—

Buyback yield%

—

◌—

—

D/E ratiox

—

1.172

Enterprise value₹B

—

1.172

—

LT debt₹M

—

Peers (US$12.44M)

Cap (US$)

Neochem Bio Solutions…

19.37M

12.04x

Archit Organosys…

15.24M

19.19x

Deepak Chemtex Limited

10.81M

10.02x

Green Oleo S.p.A.

13.99M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

2.142

17.55

Own earn%

—

Sh yield%

1.26

—

Owners

Insiders/Inst%

75.90

—

Short interest%

—

SBC / revenue%

0.35

Record

10Y

Profitable years

5/5

Revenue growth years

1/4

EPS growth years

0/4

Dividend streakyrs

Op margin range%

8–21

$1 testx

—

Incr. ROIC%

—

Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹806.5M

(4.08%)

1.00×

Cost of revenue

₹338.4M

(9.39%)

0.80×

Operating expenses

₹401.3M

11.95%

1.86×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m